NewsRx

Search our medical news database

ThromboScience, LLC

New test measures platelet, coagulation risk factor before thrombotic event

Published in Health Insurance Week, May 1st, 2005

ThromboScience, LLC, a provider of blood tests that determine cardiovascular risk, announced that it has measured a risk factor that predicts complications from heart disease in patients who have had coronary artery stenting.

Cora Yang, president of ThromboScience, said "ThromboScience offers the most comprehensive test to measure platelet reactivity and coagulation as pivotal risk factors for thrombotic events."

The test, the ThromboProfile, measures platelet reactivity and the tendency for blood clotting in a patient, the most common events that occur before a heart attack or stroke, Yang said.

ThromboScience, based in Woodside,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook